Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan ...

On this edition of GEN Live, members of the GEN and Inside Precision Medicine (IPM) editorial teams who attended JPM join the ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...

Jazz Pharmaceuticals plc recently disclosed its financial update and corporate overview at the J.P. Morgan Healthcare ...

Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...

Top Execs from Agilent, Waters, and Bruker Take the Stage at J.P. Morgan Healthcare Conference. Aaron Acevedo. The 43 rd Annual Healthcare J.P. Morgan Healthcare Conference kicked ...

This year will also doubtlessly bring deals involving artificial intelligence and related technologies. Experts predict that ...

Biopharma executives make their predictions for the year ahead, from a bold forecast for the return of the megadeal to a plea ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...